Precision for Medicine Acquires ACT Oncology         

Oncology Drug Development

Talented oncology development professionals are in high demand in the biotech and CRO industry. ACT Oncology has been remarkably successful at attracting and retaining industry leaders based on our exclusive focus on supporting oncology studies. Current and prospective team members are attracted to the company by the opportunity to collaborate on novel and promising clinical programs. Our shared passion is to alleviate the suffering caused by cancer and to contribute our talents in this cause.

To date, ACT Oncology has managed over 325 oncology programs.  Most of our clients are small to mid-sized biotech companies, looking for a combination of very specialized expertise in conducting the most complex oncology trials with a team of people they know they can count on.  Project team retention is a critical success factor in executing challenging clinical trials and ACT Oncology has a proven track record of retaining some of the most seasoned research professionals in the CRO industry.

Leave a Comment





We're changing our name and website to reflect our exciting new capabilities since joining Precision for Medicine. Please visit us at precisionforoncology.com to see how we’re delivering the next generation of CRO services for oncology innovators.